NextCure, Inc. (NXTC) Social Stream



NextCure, Inc. (NXTC): $1.67

0.04 (+2.45%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add NXTC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#90 of 360

in industry

NEXTCURE INC (NXTC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NXTC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 6 $21 $10 $15 $1.19 1160.5%
2021-11-15 6 $21 $11 $15.5 $1.19 1202.52%
2021-12-03 6 $21 $7 $14.5 $1.19 1118.49%
2021-12-13 5 $21 $7 $15.2 $1.19 1177.31%
2022-01-11 6 $21 $7 $15.5 $1.19 1202.52%
2022-02-04 7 $21 $7 $14.5 $1.19 1118.49%
2022-03-04 6 $21 $7 $14.714 $1.19 1136.47%
2022-03-13 7 $21 $7 $14.714 $1.19 1136.47%
2022-05-09 7 $21 $6 $14.142 $1.19 1088.4%
2022-05-23 7 $19 $6 $13 $1.19 992.44%
2022-08-13 6 $19 $6 $12.333 $1.19 936.39%
2022-09-17 6 $16 $6 $11.666 $1.19 880.34%
2022-11-04 5 $16 $5 $7.8 $1.19 555.46%
2022-12-02 5 $6 $1 $4.25 $1.19 257.14%
2023-08-06 5 $6 $1 $4.333 $1.19 264.12%
2023-11-03 5 $7 $1 $5 $1.19 320.17%
2023-12-14 4 $6 $3 $4.666 $1.19 292.1%

The Trend in the Analyst Price Target


Over the past 43 months, NXTC's average price target has gone down $60.67.

NXTC reports an average of 229.15% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-06 4 6 1 4.333 1.82 138.08%
2023-08-06 5 6 1 4.333 1.70 154.88%
2023-08-06 4 6 1 4.333 1.70 154.88%
2023-08-31 5 7 1 5.000 1.46 242.47%
2023-11-03 4 7 6 6.333 1.18 436.69%

NXTC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 2 1 1 0 0 4

The Trend in the Broker Recommendations


Over the past 39 weeks, NXTC's average broker recommendation rating improved by 0.75.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • NEXTCURE INC's upside potential (average analyst target price relative to current price) is greater than 2184.43% of all US stocks.
  • In terms of how NEXTCURE INC fares relative to all US stocks, note that its average analyst price target is higher than 274.25% of that group.
  • To contextualize these metrics, consider that out of all US stocks, NEXTCURE INC's variance in analysts' estimates is lower than -1732.42% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, NEXTCURE INC's number of analysts covering the stock is greater than 692.12% of them.

Stocks similar to NEXTCURE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MIST, CYCN, and APM.

What is the outlook for NXTC? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!